Introducing AnaBioSi-Data Ltd - Pioneering Personalized Cancer Treatment Through AI and Advanced Research

Welcome to AnaBioSi-Data Ltd, a visionary company founded in 2023 with a transformative goal: to make personalized cancer treatment the standard of care globally. Our innovative approach integrates in-vivo experiments and real-world patient data with cutting-edge artificial intelligence (AI) and machine learning (ML) technologies to revolutionize the prognosis, diagnosis, and treatment of cancer.

Our Vision

At AnaBioSi-Data, we are driven by the belief that every cancer patient deserves treatment tailored specifically to their unique needs. By creating sophisticated AI and ML-based software solutions, we aim to provide unparalleled personalized care that ensures the best possible health outcomes. Our dedication to translating scientific research into practical applications is poised to change the landscape of cancer treatment and significantly enhance patient well-being worldwide.

Our Achievements

In 2024, our efforts were recognized with two prestigious grants from the Research Promotion Foundation of Cyprus:

1. Enhancing Tumor Microenvironment and mRNA Vaccine Synergy through In Silico Analysis and AI-Driven Predictive Analytics

   Under the leadership of CEO Chrysovalantis Voutouri, who received the "Young Investigator Award," this project focuses on integrating in silico analysis with AI to enhance the effectiveness of mRNA vaccines in treating cancers. This grant, amounting to €51,974, supports our research from June 2024 to May 2025.

2. Ultrasound Shear Wave Elastography Driven Prognostic Tool for Precision Oncology

   In collaboration with the Cancer Biophysics Laboratory at the University of Cyprus and the German Medical Institute, this project received €600,000 to develop a prognostic tool using ultrasound shear wave elastography. This project runs from June 2024 to May 2026 and aims to refine the precision of oncological prognostics.

Our Services

AnaBioSi-Data Ltd offers a comprehensive suite of services designed to push the boundaries of medical research and patient care:

- Data & Biomarker Performance Analysis: We utilize advanced analytical techniques to evaluate and identify optimal biomarkers for diagnostic, predictive, and prognostic applications.

- Artificial Intelligence: Our AI solutions span from synthetic data generation to the development of large language models and workflow automation, all tailored to optimize data processes and drive innovation.

- Software Development: We craft customized web and mobile applications that are not only robust and scalable but also perfectly aligned with specific business and research objectives.

- In Vivo Experiments: Our team excels in conducting precise and high-quality in vivo research, crucial for the practical application of our findings in clinical settings.

- Simulation & Mathematical Modeling: We employ sophisticated modeling techniques to predict the behavior of biological systems under various conditions, enhancing our capacity to develop effective treatment strategies.

Looking Ahead

With a firm commitment to our vision and the support of our esteemed collaborators and partners, AnaBioSi-Data Ltd is continually seeking opportunities to expand our research and impact through further grants and cooperative projects with other laboratories and institutes.

We invite you to join us on this exciting journey as we strive to transform the future of cancer care, ensuring every patient receives the most effective, personalized treatment possible. Together, we can make a difference in the lives of millions affected by cancer worldwide.

For collaborations, inquiries, or more information about our research and services, please contact us. We are excited to explore how our innovative approaches can align with your research or clinical goals, paving the way for breakthrough advancements in cancer treatment.